Christopher S. James
Plus aucun poste en cours
Profil
Christopher S.
James held several positions in the finance and biotechnology industries, including Director-Investor Relations at Corcept Therapeutics, Managing Director & Senior Biotechnology Analyst at Wyche Securities, and Vice President-Investor Relations & Communications at MacroGenics.
He also worked as a Biotechnology Consultant at Cello Health BioConsulting Inc. and as an Analyst at Trivium Capital Management LLC.
James has a doctorate degree from Yale School of Medicine and an undergraduate degree from Cornell University.
Anciens postes connus de Christopher S. James
| Sociétés | Poste | Fin |
|---|---|---|
| MACROGENICS, INC. | Investor Relations Contact | 01/08/2022 |
| CORCEPT THERAPEUTICS INCORPORATED | Investor Relations Contact | 01/04/2021 |
Ladenburg Thalmann & Co., Inc. (Broker)
 Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology. | Analyst-Equity | 01/10/2017 |
FBR Capital Markets & Co. (Old)
 FBR Capital Markets & Co. (Old) Investment Banks/BrokersFinance Founded in 1989, FBR Capital Markets & Co., formerly Friedman, Billings, Ramsey & Co., is a broker/dealer headquartered in Arlington, Virginia with additional offices throughout the US. The firm is a subsidiary of FBR Capital Markets Holdings, Inc.. and their ultimate parent is FBR & Co. (NASDAQ: FBRC). In 2007, FBR Capital Markets Corp. was spun out from FBR Group as an independent investment bank, of which FBR Group retained majority ownership. FBR Capital Markets is registered with the SEC and is a member of FINRA, Nasdaq and the SIPC. FBR Capital Markets' Equity Sales & Trading Group provides institutional sales and trading services to over 1300 institutional accounts in the US, Canada, Europe, Australia and Asia. Their clients include mutual funds, hedge funds, money managers, endowments, foundations, banks, insurance companies and pension and profit sharing plans. They actively trade on behalf of clients and make markets in almost 1000 stocks traded on the NYSE, listed and OTC markets and trade more than $100 billion of securities on a per annum basis. In 2009, FBR Capital Markets began making markets in selected stocks traded on the London Stock Exchange and Euronext. In addition to agency trading in listed securities markets, they act as market-maker in Nasdaq and other OTC securities. They are one of the largest distributors of the shares of small- and mid-cap companies in public and private securities offerings and have deep trading expertise in the vertical industry groups in which the firm's investment banking and research teams specialize. These sectors include: (1) consumer (2) diversified industrials (3) energy and natural resources (4) financial institutions (5) healthcare (6) insurance (7) real estate (8) Washington policy analysis and (0) technology, media and telecommunications. The firm's analytical coverage includes a large number of small- and mid-cap companies in addition to large companies. Research is provided by FBR Capital Markets' research department, which is independent from the firm's investment banking department and has the sole authority to determine which companies receive research coverage and the recommendation contained in the coverage. | Analyst-Equity | 01/11/2016 |
Wyche Securities, Inc.
 Wyche Securities, Inc. Investment Banks/BrokersFinance Founded in 1996 by Todd Wyche, Brinson Patrick Securities Corp. is an SEC-registered broker/dealer located in New York City. The firm works exclusively with issuers to raise equity capital with little or no impact to stock price, and with a very high level of service and expertise, through their DOCS (Dynamic Offering of Common Stock) at-the-market financing facility. | Analyst-Equity | 31/01/2015 |
Formation de Christopher S. James
| Cornell University | Undergraduate Degree |
| Yale School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| MACROGENICS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Trivium Capital Management LLC
 Trivium Capital Management LLC Investment ManagersFinance Founded in 2002, Trivium Capital Management LLC is a New York City-based hedge fund manager. They manage the Trivium Offshore Fund Ltd. | Finance |
Meyers Associates LP
 Meyers Associates LP Investment Banks/BrokersFinance Founded in 1993, Meyers Associates LP is a full-service investment banking and securities brokerage firm located in New York City. The firm provides a full array of trading and execution services. They do not provide any internal research. | Finance |
Wyche Securities, Inc.
Wyche Securities, Inc. Investment Banks/BrokersFinance Founded in 1996 by Todd Wyche, Brinson Patrick Securities Corp. is an SEC-registered broker/dealer located in New York City. The firm works exclusively with issuers to raise equity capital with little or no impact to stock price, and with a very high level of service and expertise, through their DOCS (Dynamic Offering of Common Stock) at-the-market financing facility. | Finance |
Ladenburg Thalmann & Co., Inc. (Broker)
Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology. | Finance |
Cello Health BioConsulting Inc.
 Cello Health BioConsulting Inc. Miscellaneous Commercial ServicesCommercial Services Cello Health BioConsulting Inc. operates as a business development strategy consulting firm. It offers opportunity assessments, portfolio and platform strategy, and identification and evaluation of In-licensing and acquisition opportunities. The company was founded by Ed Saltzman and is headquartered in Florham Park, NJ. | Commercial Services |
FBR Capital Markets & Co. (Old)
FBR Capital Markets & Co. (Old) Investment Banks/BrokersFinance Founded in 1989, FBR Capital Markets & Co., formerly Friedman, Billings, Ramsey & Co., is a broker/dealer headquartered in Arlington, Virginia with additional offices throughout the US. The firm is a subsidiary of FBR Capital Markets Holdings, Inc.. and their ultimate parent is FBR & Co. (NASDAQ: FBRC). In 2007, FBR Capital Markets Corp. was spun out from FBR Group as an independent investment bank, of which FBR Group retained majority ownership. FBR Capital Markets is registered with the SEC and is a member of FINRA, Nasdaq and the SIPC. FBR Capital Markets' Equity Sales & Trading Group provides institutional sales and trading services to over 1300 institutional accounts in the US, Canada, Europe, Australia and Asia. Their clients include mutual funds, hedge funds, money managers, endowments, foundations, banks, insurance companies and pension and profit sharing plans. They actively trade on behalf of clients and make markets in almost 1000 stocks traded on the NYSE, listed and OTC markets and trade more than $100 billion of securities on a per annum basis. In 2009, FBR Capital Markets began making markets in selected stocks traded on the London Stock Exchange and Euronext. In addition to agency trading in listed securities markets, they act as market-maker in Nasdaq and other OTC securities. They are one of the largest distributors of the shares of small- and mid-cap companies in public and private securities offerings and have deep trading expertise in the vertical industry groups in which the firm's investment banking and research teams specialize. These sectors include: (1) consumer (2) diversified industrials (3) energy and natural resources (4) financial institutions (5) healthcare (6) insurance (7) real estate (8) Washington policy analysis and (0) technology, media and telecommunications. The firm's analytical coverage includes a large number of small- and mid-cap companies in addition to large companies. Research is provided by FBR Capital Markets' research department, which is independent from the firm's investment banking department and has the sole authority to determine which companies receive research coverage and the recommendation contained in the coverage. | Finance |
Rodman & Renshaw LLC (Old)
 Rodman & Renshaw LLC (Old) Investment Banks/BrokersFinance Founded in 2003 by Cliff Rodman and Charles Renshaw, Rodman & Renshaw LLC is a full-service investment bank and broker/dealer located in New York City with an additional office in Boston. The firm is a subsidiary of Rodman & Renshaw Capital Group (NasdaqGM: RODM). The firm provides corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. They also provide research and sales and trading services to institutional investors. Rodman & Renshaw is a leader in the PIPE and RD (registered direct offering) transaction markets. The firm's research focuses on Asia, clean technology, community & regional banks, energy, industrial and commercial services, life science/healthcare and metals and mining. Rodman & Renshaw is a member of the NASD and the SIPC. | Finance |
MSMB Capital Management LLC
 MSMB Capital Management LLC Investment ManagersFinance Founded in 2006, MSMB Capital Management LLC is a hedge fund manager located in New York City. | Finance |
Retrophin LLC
 Retrophin LLC BiotechnologyHealth Technology Retrophin, Inc. provides biotechnology services. It is a biotechnology company dedicated to developing drugs for rare and life-threatening diseases. The company was founded in 2011 and is headquartered in New York, NY. | Health Technology |
MLV & Co. LLC
 MLV & Co. LLC Investment Banks/BrokersFinance Founded in 2010, MLV & Co. LLC is a broker/dealer located in New York City. The firm is a direct subsidiary of FBR Capital Markets Holdings, Inc. and their ultimate parent is FBR & Co. (NASDAQ: FBRC), which acquired the firm in 2015. Their research focuses on small to mid-sized companies with disruptive technologies that have the potential to drive significant market changes. MLV & Co.'s coverage universe includes the life sciences, oil & gas and metals & mining sectors. | Finance |
